Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TRPC6 antibody (C-Term)

TRPC6 Reactivity: Human, Mouse WB, IHC, ELISA Host: Mouse Monoclonal 3F2-H10-F2 unconjugated
Rockland
Catalog No. ABIN964697
Supplier Product No.: 200-301-b59
  • Target See all TRPC6 Antibodies
    TRPC6 (Transient Receptor Potential Cation Channel, Subfamily C, Member 6 (TRPC6))
    Binding Specificity
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivity
    • 25
    • 17
    • 13
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Mouse
    Host
    • 24
    • 6
    • 2
    • 1
    Mouse
    Clonality
    • 28
    • 5
    Monoclonal
    Conjugate
    • 32
    • 1
    This TRPC6 antibody is un-conjugated
    Application
    • 28
    • 14
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Supplier Product No.
    200-301-b59
    Supplier
    Rockland
    Purpose
    TRPC6 Antibody
    Cross-Reactivity (Details)
    This antibody is specific for human TRPC6 protein.
    Characteristics
    Synonyms: mouse anti-TRPC6 Antibody, TRPC 6, TRP6, short transient receptor potential channel 6 and transient receptor potential cation channel subfamily C member 6
    Purification
    This product was purified from concentrated tissue culture supernate by Protein A chromatography.
    Sterility
    Sterile filtered
    Immunogen

    Immunogen: This monoclonal antibody was produced by repeated immunizations with a synthetic peptide corresponding to a region near the carboxy terminus of human TRPC6 protein.

    Immunogen Type: Conjugated Peptide

    Clone
    3F2-H10-F2
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product TRPC6 Primary Antibody
  • Application Notes

    Immunohistochemistry Dilution: 2.5 μg/mL

    Application Note: Anti-TRPC6 monoclonal antibody (200-301-B59) clone # 3F2.H10.F2 was developed by Rockland Immunochemicals Inc. against human TRPC6 using conventional hybridoma technology by fusing splenocytes of a host animal immunized with a synthetic peptide corresponding to the cytosolic domain of TRPC6 with myeloma cells. The screening of clones during the subcloning process was based on immunohistochemistry using human tissue microarrays. The pathologist analyzing the staining patterns of clones reported that the antibody shows strong to moderate staining consistent with the localization of human TRPC6 in adrenal cortex, neurons, Purkinje cells, colon epithelium, cardiac myocytes, renal tubules, hepatocytes, skeletal muscle, pancreatic exocrine and islet cells, germinal center lymphocytes, plasma cells, Sertoli cells of the testes as well as staining more faintly other tissues known to be positive for the target protein (e.g., respiratory epithelium). Prostate and placenta were negative for staining. The antibody produced minimal to no background staining and appeared very specific at 2.5 μg/mL. The pattern of reactivity observed for this clone was also similar to other antibodies used for benchmarking purposes. Specific conditions for reactivity should be optimized by the end user, however, we suggest the use of formalin-fixed paraffin-embedded sections for immunohistochemistry. No pre-treatment of sample is required. While immunohistochemistry was used as the primary screening and release validation immunoassay, clone #3F2.H10.F2 was also screened by western blotting against known positive and negative control lysates. A single band is detected by this antibody in TRPC6 positive cells and tissues, however, the molecular weight of the band (~30 kDa) is not consistent with full length human TRPC6 (181 kDa). The band detected by this antibody may be the cleaved cytosolic domain of TRPC6 as the immunogen used for antibody production corresponds to an amino acid sequence located within this domain. However, no additional data is available to elucidate the molecular composition of this band.

    Western Blot Dilution: 1:500- 1:2,000

    ELISA Dilution: 1:10,000 - 1:50,000

    Other: User Optimized

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Expiry Date
    12 months
  • Alonso-González, Cabo, San José, Gago, Suazo, García-Suárez, Cobo, Vega: "Human Digital Meissner Corpuscles Display Immunoreactivity for the Multifunctional Ion Channels Trpc6 and Trpv4." in: Anatomical record (Hoboken, N.J. : 2007), Vol. 300, Issue 6, pp. 1022-1031, (2018) (PubMed).

  • Target
    TRPC6 (Transient Receptor Potential Cation Channel, Subfamily C, Member 6 (TRPC6))
    Alternative Name
    TRPC6 (TRPC6 Products)
    Background
    Background: TRPC6, also known as TRP6, short transient receptor potential channel 6 and transient receptor potential cation channel subfamily C member 6, is thought to form a receptor-activated non-selective calcium permeant cation channel. TRPC6 is probably operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. It is activated by diacylglycerol (DAG) in a membrane-delimited fashion, independently of protein kinase C and may not to be activated by intracellular calcium store depletion. Defects in this gene are a cause of focal segmental glomerulosclerosis (FSGS). Expression of this protein has been reported in tissues such as placenta, lung, spleen, ovary, small intestine, and renal podocytes. Immunohistochemistry studies using polyclonal antibodies to this target have shown moderate to strong staining in cell types such as neurons, breast, respiratory, squamous and prostate epithelium, epidermis, placental trophoblasts, dendritic cells, and subsets of immune cells, and faint to moderate staining of adrenal, colon, ganglion cells, hepatocytes, heart, and testis.
    Gene ID
    7225, 5730102
    UniProt
    Q9Y210
You are here:
Support